Pfizer powers ahead in 2026 with strong Q1 results as pipeline momentum builds

The pharmaceutical giant reported $14.5 billion in revenue, up 5% year-over-year, and reaffirmed its full-year outlook

Emcure crosses US$1 billion revenue milestone in FY26; PAT rises 33%

Pharma major reports FY26 revenue of Rs 9,204 crore with 16.6% growth

Cipla launches next-generation oscillometer 'Ciposcillo' for respiratory diagnostics

The device is designed for early and accurate diagnosis of obstructive airway diseases such as COPD, and Asthma

OBESITAS 2026 concludes with focus on India’s rising obesity burden

The conference brought together over 500 doctors and 150 nutritionists to discuss emerging obesity-related challenges

Swiss Biotech Association reports CHF 7.5 billion revenue for Switzerland’s biotech Industry in 2025

The private funding rose 38% amid growing international collaborations and CDMO demand

Novartis locks in $23 billion US expansion with seventh new facility

The latest addition, a new API facility in Morrisville, North Carolina, will produce key components for solid dosage tablets, capsules, and RNA therapeutics

Dr Odin launches ‘Odin Buddy’ kids’ nebulizer for child-friendly respiratory care

New pediatric nebulizer combines playful design and engaging features to make breathing treatments less stressful for children and parents

NIFTY Pharma remains resilient amid mixed market sentiment

Pharma and healthcare stocks stay in focus as investors track earnings, USFDA approvals, hospital growth, and global market pressures

SetPoint Medical launches first-in-human MS pilot study using implanted nerve stimulation device

Axithra appoints Lars Kongsbak as CEO ahead of clinical validation and Series A fundraise

Precision medicine company advances Raman spectroscopy-based therapeutic drug monitoring platform for rapid, patient-specific dosing solutions